R to @EMA_News: A third of all new medicines with a positive opinion in 2023 targeted cancer , i.e. 2⃣5⃣ new cancer medicines were recommended for approval last year.

#EMAPresser

🐦🔗: https://nitter.cz/EMA_News/status/1747253496460784019#m

[2024-01-16 13:44 UTC]

R to @EMA_News: We published an overview of human medicines highlights this morning ⬇️

#EMAPresser

https://x.com/EMA_News/status/1747204037701669370?s=20

🐦🔗: https://nitter.cz/EMA_News/status/1747250732598751700#m

[2024-01-16 13:33 UTC]

R to @EMA_News: Watch live 🔴

We are now starting our press briefing on medicines that were approved last year and trends we are observing in human medicines.

Don’t miss our tweets 🧵 during the press briefing. Follow #EMAPresser

🐦🔗: https://nitter.cz/EMA_News/status/1747250220000289243#m

[2024-01-16 13:31 UTC]

R to @EMA_News: Therapeutic areas with the highest numbers of new approval recommendations:
1⃣ oncology,
2⃣ neurology,
3⃣ cardiovascular.

#EMAPresser

🐦🔗: https://nitter.cz/EMA_News/status/1747251070345077176#m

[2024-01-16 13:34 UTC]

R to @EMA_News: Half of our positive recommendations on new therapeutic indications for existing medicines were for treatment of children 👦👧

This figure is considerably higher than in previous years.

#EMAPresser #MedicinesForChildren

🐦🔗: https://nitter.cz/EMA_News/status/1747252124348723345#m

[2024-01-16 13:39 UTC]

R to @EMA_News: We provided 2 recommendations for use of medicines outside the 🇪🇺 (#EUM4All):
🔶 a new treatment option for 50 million children with a tropical disease caused by parasites
🔶a medicine to treat an acute and lethal form of sleeping sickness

@WHO #EMAPresser #GlobalHealth

🐦🔗: https://nitter.cz/EMA_News/status/1747252409414602791#m

[2024-01-16 13:40 UTC]

R to @EMA_News: Last year, we also continued our work to tackle #COVID19, in particular with the evaluation of a new vaccine and 3 updated vaccines. 💉

#EMAPresser #COVID19Vaccines

🐦🔗: https://nitter.cz/EMA_News/status/1747253014438838691#m

[2024-01-16 13:42 UTC]

R to @EMA_News: We are committed to progressing treatments against #cancer and to supporting Europe’s beating cancer plan.

Cancer is an area of high unmet medical need and a major health concern in the 🇪🇺.

#EMAPresser #EUCancerPlan #HealthUnion

🐦🔗: https://nitter.cz/EMA_News/status/1747253264356405351#m

[2024-01-16 13:43 UTC]

R to @EMA_News: To support development and earlier assessment of medicines that address unmet medical needs for #cancer patients
➡️ 7 were reviewed in view of a conditional marketing authorisation
➡️ 1 had accelerated assessment
➡️ 2 were part of the #PRIME scheme

#EMAPresser

🐦🔗: https://nitter.cz/EMA_News/status/1747253499493261624#m

[2024-01-16 13:44 UTC]

R to @EMA_News: #Cancer is an area where top innovation and scientific progress happen quickly. That’s why EMA decided to use this therapeutic area as a pathfinder to improve medicines evaluation overall. #EMAPresser

🐦🔗: https://nitter.cz/EMA_News/status/1747253899109822673#m

[2024-01-16 13:46 UTC]